中国医药
中國醫藥
중국의약
CHINA MEDICINE
2009年
3期
173-175
,共3页
李刚%褚晓凡%李卓星%占克斌%窦汝香%朱治山
李剛%褚曉凡%李卓星%佔剋斌%竇汝香%硃治山
리강%저효범%리탁성%점극빈%두여향%주치산
脑出血%纤溶活性%血肿
腦齣血%纖溶活性%血腫
뇌출혈%섬용활성%혈종
Cerebral hemorrhage%Fibrinolytic activity%Hematoma
目的 探讨脑出血患者急性期血液纤溶活性的变化规律和脑出血后血肿扩大与血液纤溶活性的关系.方法 利用发色底物法及酶联免疫吸附试验检测115例脑出血患者在发病后6、12、24 h血浆纤溶酶原活性(PLG:A)及血浆D-二聚体(D-D)水平,并与50例健康者进行比较.按血肿有否扩大,将115例脑出血患者分为血肿扩大组20例和无血肿扩大组95例,对2组PLG:A及D-D水平进行比较.结果 脑出血患者发病后6、12、24 h血中PLG:A明显低于对照组,差异有统计学意义(均P<0.05);发病后6、12、24 h血中D-D显著高于对照组,差异有统计学意义(均P<0.05);2组患者发病后6、12、24 h血中PLG:A及D-D差异无统计学意义(P均>0.05).结论 脑出血患者急性期血液纤溶活性升高,脑出血后血肿扩大与血液纤溶活性无明显相关性.
目的 探討腦齣血患者急性期血液纖溶活性的變化規律和腦齣血後血腫擴大與血液纖溶活性的關繫.方法 利用髮色底物法及酶聯免疫吸附試驗檢測115例腦齣血患者在髮病後6、12、24 h血漿纖溶酶原活性(PLG:A)及血漿D-二聚體(D-D)水平,併與50例健康者進行比較.按血腫有否擴大,將115例腦齣血患者分為血腫擴大組20例和無血腫擴大組95例,對2組PLG:A及D-D水平進行比較.結果 腦齣血患者髮病後6、12、24 h血中PLG:A明顯低于對照組,差異有統計學意義(均P<0.05);髮病後6、12、24 h血中D-D顯著高于對照組,差異有統計學意義(均P<0.05);2組患者髮病後6、12、24 h血中PLG:A及D-D差異無統計學意義(P均>0.05).結論 腦齣血患者急性期血液纖溶活性升高,腦齣血後血腫擴大與血液纖溶活性無明顯相關性.
목적 탐토뇌출혈환자급성기혈액섬용활성적변화규률화뇌출혈후혈종확대여혈액섬용활성적관계.방법 이용발색저물법급매련면역흡부시험검측115례뇌출혈환자재발병후6、12、24 h혈장섬용매원활성(PLG:A)급혈장D-이취체(D-D)수평,병여50례건강자진행비교.안혈종유부확대,장115례뇌출혈환자분위혈종확대조20례화무혈종확대조95례,대2조PLG:A급D-D수평진행비교.결과 뇌출혈환자발병후6、12、24 h혈중PLG:A명현저우대조조,차이유통계학의의(균P<0.05);발병후6、12、24 h혈중D-D현저고우대조조,차이유통계학의의(균P<0.05);2조환자발병후6、12、24 h혈중PLG:A급D-D차이무통계학의의(P균>0.05).결론 뇌출혈환자급성기혈액섬용활성승고,뇌출혈후혈종확대여혈액섬용활성무명현상관성.
Objective To investigate the changes of plasma fibrinolytic activity of patients in acute phase of cerebral hemorrhage and to evaluate the relationship between fibrinolytic activity and hematoma enlargement. Methods The PLG: A and the plasma D-D levels of 115 patients with cerebral hemorrhage were detected by means of synthetic ehromogenie substrate method and enzyme-linked immunosorbent assay (ELISA). The blood samples were obtained at 6 h, 12 h and 24 h respectively after onset of the disease. All of the pamameters were compared with 50 healthy subjects. Meanwhile 115 patients with cerebral hemorrhage were divided into two groups according to the definition of hematoma enlargement: patients with hematoma enlargement and patients without hematoma enlargement. The parameters of the two groups were compared. Results The PLG: A of patients with cerebral hemorrhage at 6 h, 12 h and 24 h after onset were significantly lower than those in control group(P < 0.05). The levels of D-D in plasma of patients with cerebral hemorrhage at 6 h , 12 h and 24 h after onset were significantly higher than those in control group(P < 0. 05). All of the observing parameters presented no significant difference between patients with hematoma enlargement and patients without hematoma enlargement. Conclusion Fibrinolytic activity of plasma increases and hematoma enlargement has no relation with fibrinolytic activity in acute phase of cerebral hemorrhage.